Many think the next standard cancer treatment will pair two innovations.

Add Yahoo as a preferred source to see more of our stories on Google. On the Wednesday, April 15, 2026, episode of The Excerpt podcast: Prices for cutting-edge medical treatments can balloon in the ...

Investors have bet new drugs can topple Merck’s Keytruda, but the evidence so far points to something smaller.

Keytruda is expected to drive another strong quarter for MRK, with investors watching Q2 sales and management's outlook ahead ...

This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. Oncology drug development is no longer a singles market as ...

Trillion Won Keytruda Biosimilar Race Heats Up Samsung Bioepis and global rivals race for market entry as MSDs 2029 patent ...

Hundreds of cancer patients have been forced to pay large sums out of pocket for a key immunotherapy drug amid ongoing delays ...

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has approved PADCEV® ...

A petition asking for cancer drug Keytruda to be funded for early-stage breast cancer has received more than 17,000 ...

On the Wednesday, April 15, 2026, episode of The Excerpt podcast: Prices for cutting-edge medical treatments can balloon in the U.S. health care system, leading to higher costs for the employer, ...